Cargando…

Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda

Epstein-Barr virus (EBV) is linked to several cancers, including endemic Burkitt lymphoma (eBL), but causal variants are unknown. We recently reported novel sequence variants in the LMP-1 gene and promoter in EBV genomes sequenced from 13 of 14 BL biopsies. Alignments of the novel sequence variants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Hsiao-Mei, Liu, Hebing, Lei, Heiyan, Li, Bingjie, Chin, Pei-Ju, Tsai, Shien, Bhatia, Kishor, Gutierrez, Marina, Epelman, Sidnei, Biggar, Robert J., Nkrumah, Francis, Neequaye, Janet, Ogwang, Martin D., Reynolds, Steven J., Lo, Shyh-Ching, Mbulaiteye, Sam M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024959/ https://www.ncbi.nlm.nih.gov/pubmed/29865259 http://dx.doi.org/10.3390/cancers10060177

Ejemplares similares

Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations
por: Lei, Haiyan, et al.
Publicado: (2015)

Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya
por: Liao, Hsiao-Mei, et al.
Publicado: (2022)

Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma
por: Xian, Rena R., et al.
Publicado: (2021)

Changes in presenting tumour site of Burkitt's lymphoma in Ghana, West Africa, 1965-1978.
por: Biggar, R. J., et al.
Publicado: (1981)

Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies
por: Derkach, Andriy, et al.
Publicado: (2018)

Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda
por: Maziarz, Marlena, et al.
Publicado: (2017)

Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western Kenya
por: Wohlford, Eric M, et al.
Publicado: (2013)

Burkitt lymphoma risk shows geographic and temporal associations with Plasmodium falciparum infections in Uganda, Tanzania, and Kenya
por: Broen, Kelly, et al.
Publicado: (2023)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study
por: Legason, Ismail D., et al.
Publicado: (2017)

Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya
por: Redmond, Lawrence S., et al.
Publicado: (2020)

Tumour site and renal dysfunction as factors influencing leucopenia after chemotherapy for Burkitt's lymphoma.
por: Biggar, R. J., et al.
Publicado: (1979)

Generating CTLs against the subdominant EBV LMP antigens by transit expression of an A20 inhibitor with EBV LMP proteins in human DCs
por: Hong, Bangxing, et al.
Publicado: (2011)

New Look of EBV LMP1 Signaling Landscape
por: Wang, Ling, et al.
Publicado: (2021)

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2
por: Zvejniece, Laura, et al.
Publicado: (2022)

A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda
por: Maziarz, Marlena, et al.
Publicado: (2018)

Burkitt Lymphoma: beyond discoveries
por: Mbulaiteye, Sam M
Publicado: (2013)

The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells
por: Zeng, Mei, et al.
Publicado: (2020)

HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
por: Lifang, Yang, et al.
Publicado: (2008)

Cancer risk in persons with HIV/AIDS in India: a review and future directions for research
por: Biggar, Robert J, et al.
Publicado: (2009)

Comparative Genomics, Infectivity and Cytopathogenicity of American Isolates of Zika Virus that Developed Persistent Infections in Human Embryonic Kidney (HEK293) Cells
por: Liu, Hebing, et al.
Publicado: (2019)

Draft Genome Sequences of Blastococcus sp. Clones TML/M2B and TML/C7B, with Different Motilities, Isolated in a Laboratory
por: Liao, Hsiao-Mei, et al.
Publicado: (2021)

A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls?
por: Baik, Sonya, et al.
Publicado: (2012)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)

Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology
por: Lei, Haiyan, et al.
Publicado: (2013)

Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
por: Fołtyn, Sylwia, et al.
Publicado: (2017)

Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study
por: Peprah, Sally, et al.
Publicado: (2021)

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)

Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
por: Guech-Ongey, Mercy, et al.
Publicado: (2010)

Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility
por: Gouveia, Mateus H., et al.
Publicado: (2020)

Seasonality of Burkitt's lymphoma in Uganda
por: Muwazi, L, et al.
Publicado: (2014)

The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation
por: Shah, Khilan M., et al.
Publicado: (2009)

Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication
por: De Leo, A, et al.
Publicado: (2015)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
por: Yang, Lifang, et al.
Publicado: (2010)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
por: Wakae, Kousho, et al.
Publicado: (2020)

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2021)

Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs
por: Sohn, Dae-Hee, et al.
Publicado: (2015)

The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey
por: Pannone, Giuseppe, et al.
Publicado: (2014)

The burden of Burkitt lymphoma in Africa
por: Hämmerl, Lucia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0vk3nieak74srlhlcdr66gop1a